The insights obtained from hospital electronic health record (EHR) software will provide an understanding of treatments prescribed and administered in German hospitals. Credit: PopTika / Shutterstock.com.

UK-based analytics company Clarivate has added German hospital prescribing insights to its Clarivate Patient Data Intelligence (CPDI) self-service platform.

This data product gathers aggregated and anonymised speciality prescribing habits across brands and diseases in hospitals across Germany.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The insights obtained from hospital electronic health record (EHR) software will provide an idea of treatments prescribed and administered in German hospitals.

Life sciences professionals can use this data to assess the prescribed drugs’ volumes by various physician specialities.

Firms in the pharma sector can leverage this to boost their commercial targeting strategies, by gaining insights on specialities with the most interest in their services over their competitors.

See Also:

Clarivate product vice-president Zoe Barker said: “Significant investment of resources is required to analyse real-world data products, particularly to understand the European market landscape, patient behaviour, and prescribing habits.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Such investment can delay the success of drug launches.

“With the addition of German hospital prescribing insights, Clarivate continues to deliver market-leading intelligence that empowers life science and healthcare organizations to create a healthier tomorrow.”

The CPDI platform offers aggregated and anonymised views of dispensing and prescribing patterns and patient behaviour.

This platform, which is claimed to be the first supplier of the new data offering, serves Italy, France, Spain, and Germany, among other markets.